Patent ID: 9605055
Date: 2017-03-28
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method for treating a cancer in an animal in need of treatment, comprising administering to said animal a composition comprising: an isolated antibody or antigen-binding fragment thereof that specifically binds to CD100, wherein the antibody or fragment thereof comprises a VH polypeptide comprising VH-CDR1, VH-CDR2, and VH-CDR3 amino acid sequences comprising SEQ ID NOs: 6, 7, and 8, respectively, and a VL polypeptide comprising VL-CDR1, VL-CDR2, and VL-CDR3 amino acid sequences comprising SEQ ID NOs: 14, 15, and 16, respectively; and a pharmaceutically acceptable carrier.